Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol CREBBP contributors: mct/npt/pgu - updated : 21-02-2018
HGNC name CREB binding protein
HGNC id 2348
ASSOCIATED DISORDERS
corresponding disease(s) RSTS , AMLT3
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
tumoral fusion      
with MYST3 in acute myeloid leukemia with translocation t(8;16)(p11;p13), see AML3, and with MLL (HRX) in therapy related acute leukemia with translocation t(11;16)(q23;p13), with MYST4 in AML with t(10;16) (q22;p13)
tumoral fusion      
fusion genes MYST3-CREBBP in acute myeloid leukemia (AML) by chromosomal translocation
tumoral somatic mutation     loss of function
in B-cell non-Hodgkin lymphoma
tumoral somatic mutation      
in relapsed acute lymphoblastic leukaemia, mutations impaired histone acetylation and transcriptional regulation of CREBBP targets, including glucocorticoid responsive genes, and may confer resistance to therapy (
tumoral somatic mutation      
in hypothalamic hamartoma with gelastic epilepsy
Susceptibility
Variant & Polymorphism
Candidate gene
Marker
Therapy target
SystemTypeDisorderPubmed
cancerhemopathy 
use of histone deacetylase inhibitors has a potential therapy in B-cell non-Hodgkin lymphoma
cancerhemopathy 
promising therapeutic targets across multiple subtypes in acute myeloid leukemia
ANIMAL & CELL MODELS
  • mice with a deletion mutation in the CBP CH1 (TAZ1) domain have an Rubinstein-Taybi Syndrome (RTS)-like phenotype that includes ASD-relevant repetitive behaviors, hyperactivity, social interaction deficits, motor dysfunction, impaired recognition memory, and abnormal synaptic plasticity